The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab brengitecan (iza-bren), an […]
Category: lung cancer
The model could lead to more targeted treatments for the disease
Lung cancer accounts for an estimated two million global diagnoses and 1.8 million deaths
The leading cause of cancer globally accounts for an estimated 1.8 million deaths annually
The platform will be used to diagnose and treat cancers, including lung and brain tumours
Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually
NSCLC is the most common type of lung cancer and is responsible for up to 85% of all […]
The third most common and serious form of cancer affects over 43,000 people every year in the UK
TMR-CT will help doctors select treatment and predict the spread of lung cancer in patients
The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359